Teladoc Health (TDOC)
(Delayed Data from NYSE)
$7.17 USD
+0.07 (0.99%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $7.18 +0.01 (0.14%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Balance Sheet
Fiscal Year End for Teladoc Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,124 | 918 | 896 | 787 | 517 |
Receivables | 217 | 211 | 169 | 169 | 57 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 30 | 56 | 73 | 57 | 0 |
Other Current Assets | 118 | 130 | 87 | 47 | 14 |
Total Current Assets | 1,489 | 1,315 | 1,225 | 1,060 | 588 |
Net Property & Equipment | 32 | 30 | 27 | 29 | 10 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 2,751 | 2,910 | 16,414 | 16,602 | 972 |
Deposits & Other Assets | 80 | 49 | 21 | 18 | 7 |
Total Assets | 4,392 | 4,345 | 17,735 | 17,755 | 1,603 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 44 | 48 | 47 | 46 | 9 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 43 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 281 | 250 | 195 | 178 | 81 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 96 | 102 | 89 | 66 | 0 |
Total Current Liabilities | 421 | 400 | 331 | 333 | 90 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 63 | 55 | 80 | 105 | 22 |
Convertible Debt | 1,539 | 1,535 | 1,226 | 1,380 | 440 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 10 | 11 | 12 | 12 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2,066 | 2,038 | 1,689 | 1,871 | 589 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 17,592 | 17,359 | 17,473 | 16,858 | 1,539 |
Retained Earnings | -15,229 | -15,008 | -1,421 | -993 | -508 |
Other Equity | -37 | -43 | -6 | 19 | -17 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 2,326 | 2,308 | 16,046 | 15,884 | 1,014 |
Total Liabilities & Shareholder's Equity | 4,392 | 4,345 | 17,735 | 17,755 | 1,603 |
Total Common Equity | 2,326 | 2,308 | 16,046 | 15,884 | 1,014 |
Shares Outstanding | 165.50 | 161.90 | 160.00 | 144.90 | 72.30 |
Book Value Per Share | 14.05 | 14.25 | 100.29 | 109.62 | 14.03 |
Fiscal Year End for Teladoc Health, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1,162 | 1,098 | 1,124 | 1,031 | 959 |
Receivables | 218 | 214 | 217 | 206 | 215 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 35 | 32 | 30 | 36 | 34 |
Other Current Assets | 131 | 142 | 118 | 115 | 113 |
Total Current Assets | 1,547 | 1,486 | 1,489 | 1,387 | 1,321 |
Net Property & Equipment | 29 | 30 | 32 | 33 | 30 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1,831 | 2,687 | 2,751 | 2,801 | 2,857 |
Deposits & Other Assets | 81 | 80 | 80 | 74 | 73 |
Total Assets | 3,524 | 4,321 | 4,392 | 4,328 | 4,316 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 56 | 38 | 44 | 26 | 16 |
Current Portion Long-Term Debt | 551 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 228 | 250 | 281 | 277 | 260 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 95 | 101 | 96 | 99 | 107 |
Total Current Liabilities | 931 | 389 | 421 | 403 | 383 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 62 | 62 | 63 | 57 | 62 |
Convertible Debt | 990 | 1,540 | 1,539 | 1,538 | 1,537 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 1 | 2 | 2 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2,022 | 2,032 | 2,066 | 2,034 | 2,021 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 17,689 | 17,638 | 17,592 | 17,535 | 17,476 |
Retained Earnings | -16,148 | -15,311 | -15,229 | -15,200 | -15,143 |
Other Equity | -39 | -39 | -37 | -42 | -39 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 1,502 | 2,289 | 2,326 | 2,294 | 2,295 |
Total Liabilities & Shareholder's Equity | 3,524 | 4,321 | 4,392 | 4,328 | 4,316 |
Total Common Equity | 1,502 | 2,289 | 2,326 | 2,294 | 2,295 |
Shares Outstanding | 171.20 | 169.50 | 165.50 | 165.50 | 164.90 |
Book Value Per Share | 8.77 | 13.50 | 14.05 | 13.86 | 13.92 |